Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Venus Concept Inc (VERO)

Venus Concept Inc (VERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,917
  • Shares Outstanding, K 7,255
  • Annual Sales, $ 76,350 K
  • Annual Income, $ -37,250 K
  • EBIT $ -28 M
  • EBITDA $ -24 M
  • 60-Month Beta 0.57
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book 0.59
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.72
  • Most Recent Earnings $-1.39 on 08/13/24
  • Next Earnings Date 11/13/24 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.64
  • Growth Rate Est. (year over year) +61,014.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3315 +21.27%
on 10/29/24
0.6486 -38.02%
on 10/22/24
-0.0776 (-16.18%)
since 10/11/24
3-Month
0.3315 +21.27%
on 10/29/24
0.9200 -56.30%
on 09/23/24
-0.2400 (-37.38%)
since 08/09/24
52-Week
0.3315 +21.27%
on 10/29/24
2.2150 -81.85%
on 02/22/24
-1.5379 (-79.28%)
since 11/10/23

Most Recent Stories

More News
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

VERO : 0.4020 (-3.60%)
Venus Concept Gains

Shares in Venus Concept Inc. (NASDAQ: VERO) moved higher Friday. The global medical aesthetic technology ...

VERO : 0.4020 (-3.60%)
VERO Stock Likely to Get Support From New Regulatory Nod in Australia

Venus Concept VERO, a leader in medical aesthetic technology, is set to strengthen its international presence following the regulatory clearance from Australia’s Therapeutic Goods Administration (TGA)...

AXGN : 13.97 (+10.35%)
KIDS : 24.98 (-2.88%)
TMDX : 89.11 (+3.64%)
VERO : 0.4020 (-3.60%)
Venus Concept: Q2 Earnings Snapshot

Venus Concept: Q2 Earnings Snapshot

VERO : 0.4020 (-3.60%)
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.4020 (-3.60%)
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.4020 (-3.60%)
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX

Clearance Expands Indications for Use to Include Non-Invasive Lipolysis of the Back and Thighs and Increases Maximum Energy Output to 150 Watts...

VERO : 0.4020 (-3.60%)
Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.4020 (-3.60%)
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.4020 (-3.60%)
Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing

TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.4020 (-3.60%)

Business Summary

Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R),...

See More

Key Turning Points

3rd Resistance Point 0.4748
2nd Resistance Point 0.4524
1st Resistance Point 0.4272
Last Price 0.4020
1st Support Level 0.3796
2nd Support Level 0.3572
3rd Support Level 0.3320

See More

52-Week High 2.2150
Fibonacci 61.8% 1.4955
Fibonacci 50% 1.2732
Fibonacci 38.2% 1.0510
Last Price 0.4020
52-Week Low 0.3315

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar